GSK-3 Inhibitor XIII

CAS No. 404828-14-4

GSK-3 Inhibitor XIII( —— )

Catalog No. M37201 CAS No. 404828-14-4

GSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 252 In Stock
5MG 242 In Stock
10MG 436 In Stock
25MG 934 In Stock
50MG 1256 In Stock
100MG 1693 In Stock
200MG 2288 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-3 Inhibitor XIII
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.
  • Description
    GSK-3 Inhibitor XIII is a potent and ATP-competitive GSK-3 inhibitor with a Ki of 24 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    404828-14-4
  • Formula Weight
    301.35
  • Molecular Formula
    C18H15N5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (331.84 mM; Ultrasonic )
  • SMILES
    N=1NC(=CC1NC=2N=C(N=C3C=CC=CC32)C=4C=CC=CC4)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Albert C Pierce, et al. CH...O and CH...N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor. J Med Chem. 2005 Feb 24;48(4):1278-81. ?
molnova catalog
related products
  • BRD5648

    BRD5648 is an inactive (R)-enantiomer of BRD0705.

  • SB 216763

    SB 216763 is a potent, selective, ATP competitive and cell permeable inhibitor GSK-3 with Ki of 9 nM (GSK-3α), equally potent for GSK-3β.

  • BIP-135

    BIP-135 is a potent and selective ATP-competitive GSK-3 inhibitor. With IC50s of 16 nM and 21 nM for GSK-3α and GSK-3β, respectively. BIP 135 exhibits neuroprotective effect.